Literature DB >> 7883994

A nonsense mutation 1669Glu-->Ter within the regulatory domain of human erythroid ankyrin leads to a selective deficiency of the major ankyrin isoform (band 2.1) and a phenotype of autosomal dominant hereditary spherocytosis.

P Jarolim1, H L Rubin, V Brabec, J Palek.   

Abstract

We describe a nonsense mutation in the regulatory domain of erythroid ankyrin associated with autosomal dominant hereditary spherocytosis with a selective deficiency of the ankyrin isoform 2.1 (55% of normal), a deficiency of spectrin (58% of normal) proportional to the decrease in ankyrin 2.1, and a normal content of the other main ankyrin isoform, protein 2.2. PCR amplification of cDNA encoding the regulatory domain of ankyrin revealed a marked decreased in the ratio of ankyrin 2.1 mRNA to the ankyrin 2.2 mRNA. Sequencing of ankyrin gene in the region where the 2.1 and 2.2 mRNA differ detected a nonsense mutation 1669Glu-->Ter (GAA-->TAA) in one ankyrin allele. Only normal ankyrin 2.1 mRNA was detected in the reticulocyte RNA. Since the alternative splicing within the regulatory domain of ankyrin retains codon 1669 in ankyrin 2.1 mRNA and removes it from ankyrin 2.2 mRNA, we propose that the 1669Glu-->Ter mutation decreases the stability of the abnormal ankyrin 2.1 mRNA allele leading to a decreased synthesis of ankyrin 2.1 and a secondary deficiency of spectrin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883994      PMCID: PMC441425          DOI: 10.1172/JCI117802

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Changing patterns in cytoskeletal mRNA expression and protein synthesis during murine erythropoiesis in vivo.

Authors:  L L Peters; R A White; C S Birkenmeier; M L Bloom; S E Lux; J E Barker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

2.  Large numbers of alternatively spliced isoforms of the regulatory region of human erythrocyte ankyrin.

Authors:  P G Gallagher; W T Tse; A L Scarpa; S E Lux; B G Forget
Journal:  Trans Assoc Am Physicians       Date:  1992

3.  Cytoplasmic regulation of mRNA function: the importance of the 3' untranslated region.

Authors:  R J Jackson
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

Review 4.  Clinical expression and laboratory detection of red blood cell membrane protein mutations.

Authors:  J Palek; P Jarolim
Journal:  Semin Hematol       Date:  1993-10       Impact factor: 3.851

Review 5.  Ankyrins: structure and function in normal cells and hereditary spherocytes.

Authors:  L L Peters; S E Lux
Journal:  Semin Hematol       Date:  1993-04       Impact factor: 3.851

6.  Complex patterns of sequence variation and multiple 5' and 3' ends are found among transcripts of the erythroid ankyrin gene.

Authors:  C S Birkenmeier; R A White; L L Peters; E J Hall; S E Lux; J E Barker
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

7.  Combined spectrin and ankyrin deficiency is common in autosomal dominant hereditary spherocytosis.

Authors:  P Savvides; O Shalev; K M John; S E Lux
Journal:  Blood       Date:  1993-11-15       Impact factor: 22.113

8.  Combined ankyrin and spectrin deficiency in hereditary spherocytosis.

Authors:  A Pekrun; S W Eber; A Kuhlmey; W Schröter
Journal:  Ann Hematol       Date:  1993-08       Impact factor: 3.673

9.  Duplication of 10 nucleotides in the erythroid band 3 (AE1) gene in a kindred with hereditary spherocytosis and band 3 protein deficiency (band 3PRAGUE).

Authors:  P Jarolim; H L Rubin; S C Liu; M R Cho; V Brabec; L H Derick; S J Yi; S T Saad; S Alper; C Brugnara
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

10.  Tissue-specific expression of distinct spectrin and ankyrin transcripts in erythroid and nonerythroid cells.

Authors:  R T Moon; J Ngai; B J Wold; E Lazarides
Journal:  J Cell Biol       Date:  1985-01       Impact factor: 10.539

View more
  6 in total

1.  Severe Ankyrin-R deficiency results in impaired surface retention and lysosomal degradation of RhAG in human erythroblasts.

Authors:  Timothy J Satchwell; Amanda J Bell; Bethan R Hawley; Stephanie Pellegrin; Kathryn E Mordue; Cees Th B M van Deursen; Nicole Heitink-Ter Braak; Gerwin Huls; Mathie P G Leers; Eline Overwater; Rienk Y J Tamminga; Bert van der Zwaag; Elisa Fermo; Paola Bianchi; Richard van Wijk; Ashley M Toye
Journal:  Haematologica       Date:  2016-05-31       Impact factor: 9.941

2.  Of mice and men: the mice were right.

Authors:  V Bennett
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

3.  Combination of two mutant alpha spectrin alleles underlies a severe spherocytic hemolytic anemia.

Authors:  H Wichterle; M Hanspal; J Palek; P Jarolim
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

4.  Identification of a novel p.Q1772X ANK1 mutation in a Korean family with hereditary spherocytosis.

Authors:  Joo Hyung Han; Seung Kim; Hoon Jang; So Won Kim; Min Goo Lee; Hong Koh; Ji Hyun Lee
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

5.  Identification of a Novel Mutation of β-Spectrin in Hereditary Spherocytosis Using Whole Exome Sequencing.

Authors:  Dżamila M Bogusławska; Michał Skulski; Beata Machnicka; Stanisław Potoczek; Sebastian Kraszewski; Kazimierz Kuliczkowski; Aleksander F Sikorski
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

6.  Effect of primary lesions in cytoskeleton proteins on red cell membrane stability in patients with hereditary spherocytosis.

Authors:  Cristina Vercellati; Anna Paola Marcello; Bruno Fattizzo; Anna Zaninoni; Agostino Seresini; Wilma Barcellini; Paola Bianchi; Elisa Fermo
Journal:  Front Physiol       Date:  2022-08-12       Impact factor: 4.755

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.